XBiotech Inc.
For the period ended Dec 31, 2025. Filed Mar 13, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 13, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 16. FORM 10–K SUMMARY
| ITEM 16. | FORM 10–K SUMMARY |
|---|
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on March 13, 2026.
| XBIOTECH INC., | |
| /s/ SUSHMA SHIVASWAMY | |
| Name: | Sushma Shivaswamy |
| Title: | Chief Executive Officer |
| (Principal Executive Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature and Title | Date |
|---|---|
| /s/ SUSHMA SHIVASWAMY Sushma Shivaswamy, Chief Executive Officer (Principal Executive Officer) | March 13, 2026 |
| /s/ ANGELA HU Angela Hu, Principal Financial Officer and Principal Accounting Officer | March 13, 2026 |
| /s/ JOHN SIMARD John Simard, Chairman of the Board | March 13, 2026 |
| /s/ THOMAS KUENDIG Thomas Kuendig, Director | March 13, 2026 |
| /s/ CRAIG RADEMAKER Craig Rademaker, Director | March 13, 2026 |
| /s/ TEVI TROY Tevi Troy, Director | March 13, 2026 |
| /s/ DAVID SOFFER David Soffer, Director | March 13, 2026 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.